Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ:CVKD
US Market
Holding CVKD?
Track your performance easily

Cadrenal Therapeutics, Inc. (CVKD) Financial Statements

74 Followers

Cadrenal Therapeutics, Inc. Financial Overview

Cadrenal Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-6.312; its P/E ratio is -1.17; Cadrenal Therapeutics, Inc. is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-1.80. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit---$ -220.09K-
EBIT$ -2.39M$ 1.66M$ -1.14M$ -11.38M$ -1.00M
EBITDA$ -2.39M$ 1.66M$ -1.14M$ -11.38M-
Net Income Common Stockholders$ -2.39M$ -1.66M$ -1.14M$ -11.38M$ -1.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 6.57M$ 8.40M$ 9.11M$ 3.23M
Total Assets$ 5.46M$ 7.05M$ 8.52M$ 9.31M$ 3.56M
Total Debt$ 8.80K$ 15.17K$ 21.35K$ 27.22K$ 32.86K
Net Debt$ 8.80K$ -6.55M$ -8.38M$ -9.08M$ -3.20M
Total Liabilities$ 1.46M$ 856.32K$ 826.88K$ 565.80K$ 383.10K
Stockholders Equity$ 3.99M$ 6.19M$ 7.69M$ 8.75M$ 3.18M
Cash Flow-
Free Cash Flow$ -1.53M$ -1.84M$ -694.45K$ -627.78K-
Operating Cash Flow$ -1.53M$ -1.84M$ -694.45K$ -627.78K-
Investing Cash Flow---$ -1.00-
Financing Cash Flow-$ 298.00$ -12.50K$ 6.51M-
Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History

Cadrenal Therapeutics, Inc. Debt to Assets

Cadrenal Therapeutics, Inc. Cash Flow

Cadrenal Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis